CXCL9 and breast carcinoma: In line with these findings, recent work has elegantly demonstrated that engineered bacterial outer membrane vesicles (OMVs) carrying CXCL9 and IL-12 can remodel the tumor microenvironment and enhance antitumor immunity in bladder and breast cancer models, including humanized mice 36.